A randomised phase II study of carmustine alone or in combination with tomour necrosis factor in patients with advanced melanoma

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 1992

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 7 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Immunoconjugates for the treatment of tumours

Grant US-9782496-B2

United States of America

Immunoconjugates for the treatment of tumours

Grant US-9119886-B2

United States of America